Advanced sequencing approaches detected insertions of viral and human origin in the viral genome of chronic hepatitis E virus patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 02 2022
Historique:
received: 08 06 2021
accepted: 17 01 2022
entrez: 3 2 2022
pubmed: 4 2 2022
medline: 9 3 2022
Statut: epublish

Résumé

The awareness of hepatitis E virus (HEV) increased significantly in the last decade due to its unexpectedly high prevalence in high-income countries. There, infections with HEV-genotype 3 (HEV-3) are predominant which can progress to chronicity in immunocompromised individuals. Persistent infection and antiviral therapy can select HEV-3 variants; however, the spectrum and occurrence of HEV-3 variants is underreported. To gain in-depth insights into the viral population and to perform detailed characterization of viral genomes, we used a new approach combining long-range PCR with next-generation and third-generation sequencing which allowed near full-length sequencing of HEV-3 genomes. Furthermore, we developed a targeted ultra-deep sequencing approach to assess the dynamics of clinically relevant mutations in the RdRp-region and to detect insertions in the HVR-domain in the HEV genomes. Using this new approach, we not only identified several insertions of human (AHNAK, RPL18) and viral origin (RdRp-derived) in the HVR-region isolated from an exemplary sample but detected a variant containing two different insertions simultaneously (AHNAK- and RdRp-derived). This finding is the first HEV-variant recognized as such showing various insertions in the HVR-domain. Thus, this molecular approach will add incrementally to our current knowledge of the HEV-genome organization and pathogenesis in chronic hepatitis E.

Identifiants

pubmed: 35110582
doi: 10.1038/s41598-022-05706-w
pii: 10.1038/s41598-022-05706-w
pmc: PMC8811047
doi:

Substances chimiques

DNA, Viral 0
RNA-Directed DNA Polymerase EC 2.7.7.49

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1720

Informations de copyright

© 2022. The Author(s).

Références

J Clin Microbiol. 2018 Apr 25;56(5):
pubmed: 29514938
J Hepatol. 2019 Jul;71(1):225-227
pubmed: 31027993
Eur J Gastroenterol Hepatol. 2008 Aug;20(8):784-90
pubmed: 18617784
Biomol Detect Quantif. 2015 Mar;3:1-8
pubmed: 26753127
J Virol. 2012 May;86(10):5697-707
pubmed: 22398290
Epidemiol Infect. 2017 Sep;145(12):2417-2423
pubmed: 28756783
Gastroenterology. 2012 May;142(6):1388-1397.e1
pubmed: 22537448
Gastroenterology. 2014 Nov;147(5):1008-11.e7; quiz e15-6
pubmed: 25181691
Microorganisms. 2020 Sep 15;8(9):
pubmed: 32942608
J Gen Virol. 2012 Mar;93(Pt 3):526-530
pubmed: 22113007
J Virol Methods. 2006 Jan;131(1):65-71
pubmed: 16125257
J Hepatol. 2016 Sep;65(3):499-508
pubmed: 27174035
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2438-43
pubmed: 21262830
Zoonoses Public Health. 2018 Feb;65(1):11-29
pubmed: 28944602
Gut. 2016 Oct;65(10):1733-43
pubmed: 27222534
J Infect Dis. 2014 Jan 15;209(2):300-3
pubmed: 23964111
J Hepatol. 2018 Jun;68(6):1256-1271
pubmed: 29609832
J Virol. 2015 Apr;89(7):3793-803
pubmed: 25609799
PLoS One. 2010 Dec 17;5(12):e14376
pubmed: 21203540
Virol J. 2010 Jun 14;7:129
pubmed: 20546601
PLoS Pathog. 2010 Jul 22;6(7):e1001005
pubmed: 20661479
Front Microbiol. 2020 Jan 31;11:1
pubmed: 32082274
RNA. 2018 Feb;24(2):183-195
pubmed: 29109157
PLoS One. 2015 Apr 08;10(4):e0124396
pubmed: 25853866
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31685465
J Viral Hepat. 2014 Jun;21(6):447-56
pubmed: 24750215
J Gen Virol. 2014 Oct;95(Pt 10):2223-2232
pubmed: 24989172
J Virol. 2014 Oct;88(20):12017-25
pubmed: 25100839
AIDS. 2014 Jun 1;28(9):1315-24
pubmed: 24698843
Clin Chem. 2020 Jan 1;66(1):217-228
pubmed: 31699702
Lancet. 2012 Jun 30;379(9835):2477-2488
pubmed: 22549046

Auteurs

C-Patrick Papp (CP)

Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, German Centre for Infection Research, Berlin, Germany.

Paula Biedermann (P)

Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, German Centre for Infection Research, Berlin, Germany.

Dominik Harms (D)

Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.

Bo Wang (B)

Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.

Marianne Kebelmann (M)

Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, German Centre for Infection Research, Berlin, Germany.

Mira Choi (M)

Department of Nephrology and Intensive Medical Care, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.

Johannes Helmuth (J)

Charité-Vivantes GmbH, Labor Berlin, Berlin, Germany.

Victor M Corman (VM)

Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, German Centre for Infection Research, Berlin, Germany.

Andrea Thürmer (A)

Genome Sequencing, Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany.

Britta Altmann (B)

Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.

Patrycja Klink (P)

Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.

Jörg Hofmann (J)

Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, German Centre for Infection Research, Berlin, Germany.
Charité-Vivantes GmbH, Labor Berlin, Berlin, Germany.

C-Thomas Bock (CT)

Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany. BockC@rki.de.
Institute of Tropical Medicine, University of Tübingen, Tubingen, Germany. BockC@rki.de.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH